Global Antiretroviral Therapy Market 2017-2021

Global Antiretroviral Therapy Market 2017-2021

Nov 2017 Technavio Infectious Disease81 Pages Price :
$ 3500
About Antiretroviral Therapy

The antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART market include the rising awareness of retroviral infection, aggressive innovation in diagnostic techniques, the introduction of novel drugs through significant investments made in R&D, and high unmet needs in the retrovirus infection treatment domain.

Technavios analysts forecast the global antiretroviral therapy market to grow at a CAGR of 2.64% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global antiretroviral therapy market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Antiretroviral Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Gilead
ViiV Healthcare
Janssen Pharmaceuticals
F. Hoffmann-La Roche

Other prominent vendors
Abbvie
Boehringer Ingelheim
Bionor Pharma
Vertex Pharmaceuticals
Mylan

Market driver
Rising awareness of retroviral infection
For a full, detailed list, view our report

Market challenge
High cost of antiretroviral drugs
For a full, detailed list, view our report

Market trend
Significant pipeline
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
Market outline
PART 05: DISEASE OVERVIEW
PART 06: MARKET LANDSCAPE
Market overview
Market size and forecast
Five forces analysis
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY DRUG CLASS
Multiclass combination products
NRTIs
Integrase inhibitors
NNRTIs
Others
PART 09: REGIONAL LANDSCAPE
Regional comparison
ART market in Americas
ART market in EMEA
ART market in APAC
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
Significant pipeline
Advanced formulations
Funding and treatment initiatives
PART 13: VENDOR LANDSCAPE
Vendor landscape
PART 14: KEY VENDOR ANALYSIS
Gilead
ViiV Healthcare
Janssen Pharmaceuticals
F. Hoffmann-La Roche
Other prominent vendors
PART 15: APPENDIX
List of abbreviations
List of Exhibits
Exhibit 01: Global ART market
Exhibit 02: Global ART market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Pipeline landscape by development phase
Exhibit 05: Key clinical trials
Exhibit 06: Global ART market by drug class 2016
Exhibit 07: Global ART market by drug class 2021
Exhibit 08: Global ART market by multiclass combination products 2016-2021 ($ millions)
Exhibit 09: Global ART market by NRTIs 2016-2021 ($ millions)
Exhibit 10: Global ART market by integrase inhibitors 2016-2021 ($ millions)
Exhibit 11: Global ART market by NNRTIs 2016-2021 ($ millions)
Exhibit 12: Global ART market by others 2016-2021 ($ millions)
Exhibit 13: Global ART market: Regional landscape
Exhibit 14: Regional comparison
Exhibit 15: ART market in Americas 2016-2021 ($ millions)
Exhibit 16: ART market in Americas Year over year growth 2017-2021
Exhibit 17: ART market in EMEA 2016-2021 ($ millions)
Exhibit 18: ART market in EMEA Year over year growth 2017-2021
Exhibit 19: ART market in APAC 2016-2021 ($ millions)
Exhibit 20: ART market in APAC Year over year growth 2017-2021
Exhibit 21: Gilead: Key highlights
Exhibit 22: Gilead: Strength assessment
Exhibit 23: Gilead: Strategy assessment
Exhibit 24: Gilead: Opportunity assessment
Exhibit 25: ViiV Healthcare: Key highlights
Exhibit 26: ViiV Healthcare: Strength assessment
Exhibit 27: ViiV Healthcare: Strategy assessment
Exhibit 28: ViiV Healthcare: Opportunity assessment
Exhibit 29: Janssen Pharmaceuticals: Key highlights
Exhibit 30: Janssen Pharmaceuticals: Strength assessment
Exhibit 31: Janssen Pharmaceuticals: Strategy assessment
Exhibit 32: Janssen Pharmaceuticals: Opportunity assessment
Exhibit 33: F. Hoffmann-La Roche: Key highlights
Exhibit 34: F. Hoffmann-La Roche: Strength assessment
Exhibit 35: F. Hoffmann-La Roche: Strategy assessment
Exhibit 36: F. Hoffmann-La Roche: Opportunity assessment

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3500
$ 5000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top